Clinical perspective: Acromegaly and cancer: Not a problem?

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 2929-2934

  Helmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLON POLYP; GROWTH DISORDER; GROWTH HORMONE RELEASE; HUMAN; METABOLIC DISORDER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ADENOMA; ANIMAL; HYPOPHYSIS TUMOR; METABOLISM; MORTALITY; NEOPLASM; SECRETION;

ACROMEGALY; ADENOMA; ANIMALS; COLONIC POLYPS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; PITUITARY NEOPLASMS;

EID: 0035404392     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.2929     Document Type: Review

References (70)

1. Acromegaly
2. Clinical manifestations of acromegaly
3. Unwanted effects of growth hormone excess in the adult
4. Clinical Review 18. Are patients with acromegaly at increased risk for neoplasia?
5. Mortality in acromegaly
6. Epidemiology of acromegaly in the Newcastle region
7. Acromegaly
8. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984
9. An audit of outcome of treatment in acromegaly
10. Acromegaly: An epidemiological study
11. Determinants of clinical outcome and survival in acromegaly
12. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results
13. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
14. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly
15. Criteria for cure of acromegaly: A consensus statement
16. IGFs and cell growth
17. Molecular and cellular aspects of the insulin-like growth factor I receptor
18. Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor
19. Growth hormone treatment induces mammary gland hyperplasia in aging primates
20. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly
21. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
22. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
23. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism
24. Insulin-like growth factor receptor expression and function in human breast cancer
25. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant
26. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors
27. Actions of IGF system proteins from studies of transgenic and gene knockout models
28. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice
29. Neoplasms in rats treated with pituitary growth hormone I. pulmonary and lymphatic tissues
30. Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo
31. High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice
32. Surgical hypophysectomy in patients with cancer
33. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
34. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
35. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
36. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
37. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults
38. Colonic polyps in patients with acromegaly
39. Acromegaly and colon cancer
40. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer
41. Colon polyps in acromegaly
42. Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours?
43. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age
44. Increased prevalence of colonic adenomas in patients with acromegaly
45. The prevalence of colonic polyps in acromegaly: A colonoscopic and pathological study in 103 patients
46. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly
47. Acromegaly, colonic polyps and carcinoma
48. Colorectal neoplasia in acromegaly
49. Acromegaly and colon cancer
50. The prevalence and characteristics of colorectal neoplasia in acromegaly
51. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly
52. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
53. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
54. IGFs and the digestive tract
55. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I
56. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone
57. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men
58. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
59. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history
60. Increased incidence of neoplasia in females with acromegaly
61. Skin tags as a marker for adenomatous polyps of the colon
62. Acromegaly and colonic cancer
63. Increased incidence of neoplasia in patients with pituitary adenomas
64. Gastrointestinal tumors in acromegalic patients
65. Benign and malignant tumors in patients with acromegaly
66. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects
67. Occurrence of cancer in acromegaly and in hypopituitarism
68. Acromegaly and gastrointestinal cancer
69. Mortality and cancer incidence in acromegaly: A retrospective cohort study